clinical trial · NCT07124013
A Study of Olomorasib (LY3537982) in Healthy Japanese Participants
Eli Lilly and Company·phase1·completed·n = 191
HealthyOlomorasib
brief summary
The purpose of this study is to compare and see how food affects the amount of olomorasib in the blood when olomorasib is taken in two different capsule forms. Participation in the study will last approximately 6 weeks.
started
Sep 16, 2025
primary completion
Jan 5, 2026
completion
Jan 5, 2026
last updated
Jan 16, 2026
official title
An Open-Label, Phase 1 Study to Investigate the Comparability of the Pharmacokinetics of Olomorasib (LY3537982) Between Two Capsule Formulations and to Evaluate the Food Effect in Healthy Japanese Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol